Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-538-1 | CAS number: 142-47-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Two bacterial mutation tests and two chromosomal aberration tests showed negative results.
The in vivo micronucleus test showed that monosodium glutamate has no clastogenic activity in bone marrow cells of mice (negative).
Monosodium glutamate administration at levels up to 5.0% in the diet was not carcinogenic for male and female Fischer 344 rats in the carcinogenicity study.
Based on the results of the in vivo micronucleus test and the carcinogenicity study, the mouse lymphoma study does not appear scientifically necessary.
Short description of key information:
Monosodium glutamate has been tested in two bacterial reverse mutation tests (equivalent to OECD 471 and GLP), two chromosomal aberration tests (equivalent to OECD 473 and GLP), in vivo micronucleus test (equivalent to OECD 474 and GLP) and carcinogenicity data.
Bacterial reverse mutation tests, OECD 471 (according to GLP principles):
E. coli, S. typhimurium TA 1535, TA 1537, TA 98 and TA 100 were tested with and without metabolic activation up to 5000 µg/plate. It was concluded
that the test substance is not mutagenic under the current test conditions.
Chromosomal aberration tests, OECD 473 (according to GLP principles):
Cultured Chinese Hamster Lung cells were tested with and without metabolic activation up to 1.9 mg/ml. It was concluded that the test substance is not clastogenic under the current test conditions.
In vivo micronucleus test, OECD 474 (according to GLP principles):
Monosodium L-glutamate monohydrate was administered (gavage) to male ICR mouse. The dose range was as follow: 500, 1000 and 2000 mg/kg bw/day - 5 animals per group. No treatment related effect was observed. It was concluded that the test substance is not clastogenic under the current test conditions.
Carcinogenicity, study performed in agreement with OECD 451.
Monosodium L-glutamate was administered (gavage) to female and male Fischer 344 rats. The dose range was 0.6, 1.25, 2.5 and 5.0% (this dose level was equivalent to 1982 mg/kg bw/day for males and 2311 mg/kg bw/day for females) for 104 weeks - 50 animals per group. Effects observed were
increased urinary volume (males, 5% w/w), increased pH and sodium levels and reduced urinary potassium levels (males and females, 2.5% w/w and
5% w/w) , increased relative kidney weight (males and females, 5% w/w) and increased urinary bladder weight (males, 5% w/w). Due to the limited
number of parameters measured it is not appropriate to derive a NOAEL for toxicity from the results of this study.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
It can be concluded that monosodium glutamate is not considered mutagenic/clastogenic according to DSD and CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.